2012
DOI: 10.1021/nn3023969
|View full text |Cite
|
Sign up to set email alerts
|

Electrochemical Immunosensors for Detection of Cancer Protein Biomarkers

Abstract: Bioanalytical methods have experienced unprecedented growth in recent years, driven in large part by the need for faster, more sensitive, more portable ("point of care") systems to detect protein biomarkers for clinical diagnosis. Electrochemical detection strategies, used in conjunction with immunosensors, offer advantages because they are fast, simple, and low cost. Recent developments in electrochemical immunosensors have significantly improved the sensitivity needed to detect low concentrations of biomarke… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
357
0
2

Year Published

2014
2014
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 636 publications
(361 citation statements)
references
References 105 publications
(222 reference statements)
2
357
0
2
Order By: Relevance
“…Because the performance of the uMED and the variety of important pulse sequences that it can perform are comparable to the commercial comparison, the uMED can, in principle, be used in place of an expensive (US$1,000-50,000) bench-top potentiostat in other applications that use these common electrochemical methods. For example, the uMED could use amperometry to detect metabolites (33), proteins, or other biomolecules, or voltammetry to perform immunoassays in which an antibody is labeled with an enzyme (e.g., electrochemical ELISA), metal nanoparticle, or quantum dot (2,24). The vast and fast-growing field of ISEs also provides many opportunities to couple new electrodes with the uMED to measure diverse analytes by potentiometry (34), such as blood urea nitrogen and creatinine (35), which are biomarkers for kidney function.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Because the performance of the uMED and the variety of important pulse sequences that it can perform are comparable to the commercial comparison, the uMED can, in principle, be used in place of an expensive (US$1,000-50,000) bench-top potentiostat in other applications that use these common electrochemical methods. For example, the uMED could use amperometry to detect metabolites (33), proteins, or other biomolecules, or voltammetry to perform immunoassays in which an antibody is labeled with an enzyme (e.g., electrochemical ELISA), metal nanoparticle, or quantum dot (2,24). The vast and fast-growing field of ISEs also provides many opportunities to couple new electrodes with the uMED to measure diverse analytes by potentiometry (34), such as blood urea nitrogen and creatinine (35), which are biomarkers for kidney function.…”
Section: Discussionmentioning
confidence: 99%
“…electrochemistry | mHealth | point-of-care diagnostics | low-cost potentiostat | telemedicine E lectrochemistry provides a broad array of quantitative methods for detecting important analytes (e.g., proteins, nucleic acids, metabolites, metals) for personal and public health, clinical analysis, food and water quality, and environmental monitoring (1,2). Although useful in a variety of settings, these methodswith the important exception of blood glucose meters (3,4)-are generally limited to well-resourced laboratories run by skilled personnel.…”
mentioning
confidence: 99%
“…This paper's section will be devoted to the description of the some innovative electrochemical immunosensors for the detection of clinically important protein biomarkers. In particular, we focus our attention on label-free and no-label free electrochemical immunosensors based on the use of SPEs coupled with gold nanoparticles, carbon nanotubes, graphene, magnetic particles and quantum dots (QDs) as new strategies to improve the analytical performances of the conventional SPE-immunosensors [36].…”
Section: Innovative Electrochemical Immunosensors Based On the Use Ofmentioning
confidence: 99%
“…Developing ultrasensitive, quantitative, and cost‐effective methodologies for the detection of disease‐related low‐abundance biomarkers is becoming an unstoppable trend and should be seen as an exciting challenge 1. Enzyme‐based colorimetric assays are widely recognized as such kind of techniques around the world for clinical detections, thanks to their easy operation, straightforward readout, and good practicality 2.…”
Section: Introductionmentioning
confidence: 99%